198 related articles for article (PubMed ID: 20308079)
1. Long chain acyl-CoA synthetase-3 is a molecular target for peroxisome proliferator-activated receptor delta in HepG2 hepatoma cells.
Cao A; Li H; Zhou Y; Wu M; Liu J
J Biol Chem; 2010 May; 285(22):16664-74. PubMed ID: 20308079
[TBL] [Abstract][Full Text] [Related]
2. A novel peroxisome proliferator response element modulates hepatic low-density lipoprotein receptor gene transcription in response to PPARδ activation.
Shende VR; Singh AB; Liu J
Biochem J; 2015 Dec; 472(3):275-86. PubMed ID: 26443862
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation of hepatic ACSL3 and ACSL5 by oncostatin m reduces hypertriglyceridemia through enhanced beta-oxidation.
Zhou Y; Abidi P; Kim A; Chen W; Huang TT; Kraemer FB; Liu J
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2198-205. PubMed ID: 17761945
[TBL] [Abstract][Full Text] [Related]
4. Identification of Hepatic Lysophosphatidylcholine Acyltransferase 3 as a Novel Target Gene Regulated by Peroxisome Proliferator-activated Receptor δ.
Singh AB; Liu J
J Biol Chem; 2017 Jan; 292(3):884-897. PubMed ID: 27913621
[TBL] [Abstract][Full Text] [Related]
5. PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro.
Kan CF; Singh AB; Dong B; Shende VR; Liu J
Biochim Biophys Acta; 2015 May; 1851(5):577-87. PubMed ID: 25645621
[TBL] [Abstract][Full Text] [Related]
6. PPARdelta increases expression of the human apolipoprotein A-II gene in human liver cells.
Thulin P; Glinghammar B; Skogsberg J; Lundell K; Ehrenborg E
Int J Mol Med; 2008 Jun; 21(6):819-24. PubMed ID: 18506377
[TBL] [Abstract][Full Text] [Related]
7. Reduction of serum free fatty acids and triglycerides by liver-targeted expression of long chain acyl-CoA synthetase 3.
Wu M; Cao A; Dong B; Liu J
Int J Mol Med; 2011 May; 27(5):655-62. PubMed ID: 21347510
[TBL] [Abstract][Full Text] [Related]
8. Suppression of long chain acyl-CoA synthetase 3 decreases hepatic de novo fatty acid synthesis through decreased transcriptional activity.
Bu SY; Mashek MT; Mashek DG
J Biol Chem; 2009 Oct; 284(44):30474-83. PubMed ID: 19737935
[TBL] [Abstract][Full Text] [Related]
9. High-fructose diet downregulates long-chain acyl-CoA synthetase 3 expression in liver of hamsters via impairing LXR/RXR signaling pathway.
Dong B; Kan CF; Singh AB; Liu J
J Lipid Res; 2013 May; 54(5):1241-54. PubMed ID: 23427282
[TBL] [Abstract][Full Text] [Related]
10. Hepatic expression of long-chain acyl-CoA synthetase 3 is upregulated in hyperlipidemic hamsters.
Wu M; Liu H; Chen W; Fujimoto Y; Liu J
Lipids; 2009 Nov; 44(11):989-98. PubMed ID: 19756806
[TBL] [Abstract][Full Text] [Related]
11. Carbacyclin induces carnitine palmitoyltransferase-1 in cardiomyocytes via peroxisome proliferator-activated receptor (PPAR) delta independent of the IP receptor signaling pathway.
Kuroda T; Hirota H; Fujio Y; Sugiyama S; Masaki M; Hiramoto Y; Shioyama W; Okamoto K; Hori M; Yamauchi-Takihara K
J Mol Cell Cardiol; 2007 Jul; 43(1):54-62. PubMed ID: 17540403
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor-delta upregulates 14-3-3 epsilon in human endothelial cells via CCAAT/enhancer binding protein-beta.
Brunelli L; Cieslik KA; Alcorn JL; Vatta M; Baldini A
Circ Res; 2007 Mar; 100(5):e59-71. PubMed ID: 17303761
[TBL] [Abstract][Full Text] [Related]
13. SREBP2 Activation Induces Hepatic Long-chain Acyl-CoA Synthetase 1 (ACSL1) Expression in Vivo and in Vitro through a Sterol Regulatory Element (SRE) Motif of the ACSL1 C-promoter.
Singh AB; Kan CF; Dong B; Liu J
J Biol Chem; 2016 Mar; 291(10):5373-84. PubMed ID: 26728456
[TBL] [Abstract][Full Text] [Related]
14. Activation of LXR increases acyl-CoA synthetase activity through direct regulation of ACSL3 in human placental trophoblast cells.
Weedon-Fekjaer MS; Dalen KT; Solaas K; Staff AC; Duttaroy AK; Nebb HI
J Lipid Res; 2010 Jul; 51(7):1886-96. PubMed ID: 20219900
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases.
Ndiaye H; Liu JY; Hall A; Minogue S; Morgan MY; Waugh MG
Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32286604
[TBL] [Abstract][Full Text] [Related]
16. Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter.
Schoonjans K; Watanabe M; Suzuki H; Mahfoudi A; Krey G; Wahli W; Grimaldi P; Staels B; Yamamoto T; Auwerx J
J Biol Chem; 1995 Aug; 270(33):19269-76. PubMed ID: 7642600
[TBL] [Abstract][Full Text] [Related]
17. VLDL hydrolysis by hepatic lipase regulates PPARδ transcriptional responses.
Brown JD; Oligino E; Rader DJ; Saghatelian A; Plutzky J
PLoS One; 2011; 6(7):e21209. PubMed ID: 21750705
[TBL] [Abstract][Full Text] [Related]
18. Mouse carnitine-acylcarnitine translocase (CACT) is transcriptionally regulated by PPARalpha and PPARdelta in liver cells.
Gutgesell A; Wen G; König B; Koch A; Spielmann J; Stangl GI; Eder K; Ringseis R
Biochim Biophys Acta; 2009 Oct; 1790(10):1206-16. PubMed ID: 19577614
[TBL] [Abstract][Full Text] [Related]
19. Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.
Vu-Dac N; Schoonjans K; Kosykh V; Dallongeville J; Fruchart JC; Staels B; Auwerx J
J Clin Invest; 1995 Aug; 96(2):741-50. PubMed ID: 7635967
[TBL] [Abstract][Full Text] [Related]
20. The PPARdelta agonist GW501516 suppresses interleukin-6-mediated hepatocyte acute phase reaction via STAT3 inhibition.
Kino T; Rice KC; Chrousos GP
Eur J Clin Invest; 2007 May; 37(5):425-33. PubMed ID: 17461989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
